Eranga Roshan Balasooriya
8PUBLICATIONS
86CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|May 12, 2025
Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets.Vindhya Vijay, Negin Karisani, Lei Shi
|May 07, 2024
FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.Yuanli Zhen, Kai Liu, Lei Shi
|Mar 04, 2024
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations.Eranga R Balasooriya, Qibiao Wu, Haley Ellis
|Oct 17, 2023
Integrating Clinical Cancer and PTM Proteomics Data Identifies a Mechanism of ACK1 Kinase Activation.Eranga R Balasooriya, Deshan Madhusanka, Tania P López-Palacios
|Oct 16, 2023
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma.Qibiao Wu, Haley Ellis, Giulia Siravegna
|Oct 16, 2021
SGK2, 14-3-3, and HUWE1 Cooperate to Control the Localization, Stability, and Function of the Oncoprotein PTOV1.Katie L Pennington, Colten M McEwan, James Woods
Pageof 2
Frequent Collaborators
4 joint publications
Yuanli Zhen
4 joint publications
Nabeel Bardeesy
3 joint publications
Joshua L Andersen
3 joint publications
Vanessa S Silveira
3 joint publications
Haley Ellis
3 joint publications
Qibiao Wu
2 joint publications
Katie L Pennington
2 joint publications
Ryan B Corcoran
2 joint publications
Stephen R Piccolo
2 joint publications
Bryanna L Norden
